Technology and Innovation
by Jenna Ogilvie | Apr 19, 2021 | Commentary, Perspectives
In 2021, as the majority of the world’s population eagerly waits to receive safe and effective COVID-19 vaccines, factories worldwide are producing bits of the vaccine components—mRNA, lipids, proteins, key reagents, and attenuated viruses—and then assembling...
by Jenna Ogilvie | Nov 30, 2020 | Discussion Paper, Perspectives
The health care ecosystem is witnessing a surge of artificial intelligence (AI)-driven technologies and products that can potentially augment care delivery outside of hospital and clinic settings. These tools can be used to conduct remote monitoring, support...
by Jenna Ogilvie | Dec 16, 2019 | Commentary, Perspectives
Reflecting on my Patient Experience Doctors told me I had a large tumor attached to a nerve in my spinal cord. The tumor was precariously expanding into my chest cavity, and there was a likelihood of paralysis if I did not act. Surgery was my only option. I am...
by Jenna Ogilvie | Oct 28, 2019 | Discussion Paper, Perspectives
Foreword The Global Future Council on Neurotechnologies represents a diverse group of experts drawn from psychiatry, psychology, brain science, technology, advocacy and the public sector. They are passionate about stimulating the global conversation on mental...
by Jenna Ogilvie | Sep 30, 2019 | Discussion Paper, Perspectives
Introduction Cell-, gene-, and tissue-based advanced therapeutic products, referred to in this paper as “cell and gene therapy” (CGT) products, have the potential to address many unmet medical needs. These products are commonly discovered and developed in...
Page 1 of 1012345...10...»Last »
